We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$180M
AUM Growth
+$6.46M
Cap. Flow
-$30.8M
Cap. Flow %
-17.07%
Top 10 Hldgs %
57.53%
Holding
51
New
2
Increased
3
Reduced
42
Closed
1

Top Buys

Rank Stock Value
1
CAT icon
Caterpillar
CAT
+$196K
2
DE icon
Deere & Co
DE
+$190K
3
ALXN
Alexion Pharmaceuticals
ALXN
+$52.4K
4
VMW
VMware, Inc
VMW
+$10.1K
5
ADBE icon
Adobe
ADBE
+$2.06K

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$29M
2
CAVM
Cavium, Inc.
CAVM
+$381K
3
KITE
Kite Pharma, Inc.
KITE
+$366K
4
MELI icon
Mercado Libre
MELI
+$217K
5
CELG
Celgene Corp
CELG
+$165K

Sector Composition

Rank Sector Weight
1 Healthcare 31.65%
2 Technology 25.32%
3 Consumer Discretionary 24.58%
4 Communication Services 13.24%
5 Industrials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HD icon
26
Home Depot
HD
$335B
$1.09M 0.6%
5,731
-61
-1% -$10.5K
BMY icon
27
Bristol-Myers Squibb
BMY
$128B
$777K 0.43%
12,679
-324
-2% -$20.3K
JNJ icon
28
Johnson & Johnson
JNJ
$641B
$752K 0.42%
5,380
-169
-3% -$23.5K
KMI icon
29
Kinder Morgan
KMI
$70.6B
$696K 0.39%
38,515
-1,611
-4% -$28.9K
NSC icon
30
Norfolk Southern
NSC
$77.1B
$692K 0.38%
4,778
-1
-0% -$134
ABT icon
31
Abbott
ABT
$182B
$676K 0.37%
11,846
-290
-2% -$16.1K
NEE icon
32
NextEra Energy
NEE
$185B
$581K 0.32%
14,892
-104
-0.7% -$4.01K
T icon
33
AT&T
T
$167B
$512K 0.28%
17,437
-437
-2% -$11.9K
JPM icon
34
JPMorgan Chase
JPM
$947B
$509K 0.28%
4,762
-230
-5% -$23.3K
LLY icon
35
Eli Lilly
LLY
$1.07T
$500K 0.28%
5,923
-140
-2% -$11.9K
PFE icon
36
Pfizer
PFE
$141B
$474K 0.26%
13,794
-247
-2% -$8.42K
PAYX icon
37
Paychex
PAYX
$41.1B
$428K 0.24%
6,290
-350
-5% -$23K
MRK icon
38
Merck
MRK
$323B
$366K 0.2%
6,819
-105
-2% -$5.82K
NUE icon
39
Nucor
NUE
$56.4B
$337K 0.19%
5,301
-275
-5% -$16.1K
VZ icon
40
Verizon
VZ
$198B
$304K 0.17%
5,734
-159
-3% -$7.82K
COST icon
41
Costco
COST
$422B
$302K 0.17%
1,625
-140
-8% -$24.2K
TROW icon
42
T. Rowe Price
TROW
$25.5B
$289K 0.16%
2,755
-113
-4% -$11K
CVX icon
43
Chevron
CVX
$378B
$268K 0.15%
2,140
-50
-2% -$5.93K
SLB icon
44
SLB Ltd
SLB
$76.5B
$267K 0.15%
3,962
-180
-4% -$11.7K
IP icon
45
International Paper
IP
$22.5B
$239K 0.13%
4,353
– –
DUK icon
46
Duke Energy
DUK
$100B
$232K 0.13%
2,757
– –
CAT icon
47
Caterpillar
CAT
$402B
$223K 0.12%
+1,414
New +$196K
WBA
48
DELISTED
Walgreens Boots Alliance
WBA
$215K 0.12%
2,965
-295
-9% -$20.8K
DE icon
49
Deere & Co
DE
$169B
$213K 0.12%
+1,360
New +$190K
ET icon
50
Energy Transfer Partners
ET
$68.5B
$178K 0.1%
10,311
– –
1
2
3

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return
VM
Venator Management Pittsburgh, Pennsylvania $416M AUM 16.01% 1-Year Est. Return

Bender Robert & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Bender Robert & Associates held 51 positions worth $180M, up 3.7% from $174M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Bender Robert & Associates withdrew a net $30.8M in Q4 2017, closing 1 position and reducing 42 holdings. Its most notable exit was Kite Pharma, Inc., an estimated $366K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Bender Robert & Associates opened a new position in Caterpillar worth $223K.

  • Bender Robert & Associates's largest Q4 2017 buy was Caterpillar: 1,414 shares worth $223K.
  • Bender Robert & Associates added most to Alexion Pharmaceuticals in Q4 2017, an estimated $52.4K increase.
  • Bender Robert & Associates's biggest Q4 2017 reduction was Intuitive Surgical, cutting an estimated $29M.
  • Bender Robert & Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $366K.
  • Bender Robert & Associates's ten largest holdings make up 58% of its $180M portfolio in Q4 2017.
  • Bender Robert & Associates opened 2 new positions and closed 1 in Q4 2017.
  • Bender Robert & Associates's portfolio value rose 3.7% quarter-over-quarter to $180M.

Based on Bender Robert & Associates's 13F filing for Q4 2017, filed 19 Jan 2018.